InvestorsHub Logo
icon url

Stillmoremanz

04/23/24 11:09 PM

#197273 RE: BonnieMac #197271

We're all trying to figure that out.
icon url

MrMyers

04/23/24 11:45 PM

#197276 RE: BonnieMac #197271

Agreed. The company has not been transparent in the least. I have the following specific questions:
1) Did the SAGA deal go through? It doesn't appear to have gone through. Biogenysis and Virogentics appear to be part of ENZC. The Biogenysis website is down -- perhaps for the same reason that the ENZC website was down. If ENZC comments when the website is restored, I'll be confident that both Biogenysis and Virogentics are definitely still in the ENZC family.
2) Is the SAGA deal still in the works?
3) ENZC's exec team is clearly taking the company in a new direction. The verbiage in today's AccessWire article layered on more anxiety for SH's (at least me). To my knowledge, only Virogentics has ANY experience in "Sales, Marketing and Distribution". Let's be honest here -- it isn't much experience. I'm thinking WTF?
4) How does Dr. Chandra fit into the company's future? Is he still CEO of Biogenysis and a ENZC Board member?
5) I've read many times that the patents (intellectual property) are held in the "Zhabilov Trust" and that ENZC/Biogenysis is the exclusive licensee for the patents. ENZC's future value has been all about the future value of the intellectual property. Now the exec team is changing the strategy/model to "sales, marketing and distribution". What are they selling, marketing and distributing? Surely not "IPF Immune Support". Is the new strategy wrapped around AI and human monoclonal antibodies? If so, they're basically selling/marketing/distributing intellectual property.

Well, I just don't know. Does anyone?
icon url

Dyno89

04/23/24 11:55 PM

#197277 RE: BonnieMac #197271

The valuable assets are still under BGEN, which is still under SAGA. If the deal was off or being reversed as people want to believe now to have some shred of hope left for themselves, why did the recent PR from the new ENZC ceo even tell everyone that they were proceeding with FINRA to attempt to issue the SAGA dividend shares. The deal went through, the despac is what didn’t. SAGA is no longer a Nasdaq company, so the SEC won’t do anything. Not like they would have before probably. They are going to try to justify “doing right by the shareholders” by giving out the SAGA shares still, which will be worthless. People are trying to come up with anything they can at this point to not have to come to terms with the disaster and losses here. It is what it is. Writing was on the wall for a long time. Even when things were seemingly going well here, we were trading at .03-.04 cents. It could be a year or two if things went all ENZC’s way from here on out with the SAGA mess and the lawsuit etc. Only at that point a year or more from now would there be any potential progress with what’s left under ENZC (if Harry brings ITV or IPF back under this), and then what? More waiting on Africa trials? Nothing happened in a full three years when things were on track and then it all derailed. If they ever got back on track (minus Clone 3 and BGEN assets under the Cotropias or Chandra) would it even be worth .02 cents again? Doubt it, after how many people are now turned off to this for good. Does anyone really think that Charles is out as CEO and Chandra walked away too (clearly signaling internal issues in the management) and that those assets like Clone 3 and the rest would ever find their way back under ENZC with Harry having control now? Get real. Clone 3 was the only reason I ever invested here and that’s gone for good for sure. No chance the Cotropias patents or assets come back under Harry’s control in a company they were just outed from (or purposely prior to the vote of new management, walked away from).